Angoron 150 mg/3 ml amp ενέσιμο διάλυμα clinical trials

A perspective multicenter randomized clinical trial for the safety and efficacy of flecainide compared to amiodorone for the conversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary disease without residual ischemia and ejection fraction >35% (FLECA-ED)

This study looks at two medicines, flecainide and amiodarone, to see which is better and safer at steadying a fast, irregular heartbeat called atrial fibrillation in the emergency room. It's for people with heart artery disease who don't have new heart damage and whose heart pumps well.